Custom Synthesis

Introduction Covalently attaching functional peptide vectors to synthetic nucleic acids can substantially modify the pharmacokinetics and biodistribution of oligonucleotide therapeutics […]

Introduction: Peptide-oligonucleotide conjugate (POC) developers face a question that shapes every downstream decision — from IND strategy to exclusivity planning:

Introduction Optimizing Linker Hydrolytic Stability is a foundational chemical strategy for preventing premature payload dissociation during systemic circulation while still

Introduction Peptide-Oligonucleotide Conjugate Sequence Confirmation Strategies integrate multi-stage tandem mass spectrometry (MS/MS) with targeted enzymatic digestion to achieve comprehensive primary

Introduction NMR-Based Structural Elucidation provides a definitive analytical approach for determining the three-dimensional architecture, solution-state dynamics, and covalent linkage geometry

Introduction: Peptide-Oligonucleotide Conjugates for Blood-Brain Barrier Delivery are being explored because conventional oligonucleotides generally struggle to reach therapeutic concentrations in

Introduction: The FDA Regulatory Pathway for Peptide-Oligonucleotide Conjugates is not determined simply by identifying a product as either a peptide

Introduction: Analytical characterization of peptide-oligonucleotide conjugates becomes significantly more complex once a molecule moves from a single-linker design to a

Introduction Engineering a Cell-Penetrating Peptide Conjugate provides a strategy for the non-invasive delivery of therapeutic antisense oligonucleotides across the blood-brain

Introduction: Automation in Peptide-Oligonucleotide Conjugate Synthesis is becoming increasingly important as researchers seek more reproducible and scalable ways to manufacture